In Trinidad and Tobago, the people living with hiv antiretroviral therapy coverage stands at 60% currently, a decrease of 1% (-1.6%) compared to 2021.
People living with HIV antiretroviral therapy coverage in Trinidad and Tobago
No matching regions
Source:
Data availability:
Regions:
215
Date range: 2000 to 2022
Points:
13,760
Measure:
%
Similar regions to Trinidad and Tobago
Antiretroviral therapy coverage
More indicators for Trinidad and Tobago
Male unintentional poisoning
0.1
0.0
(2019)
Female wasting in children
7.1%
+2.5%
(2011)
Female prevalence of HIV
0.3%
+0.1%
(2022)
Out-of-pocket expenditure PPP per capita
intl dollar817
-intl dollar59
(2021)
Birth registration
96.5%
-0.1%
(2011)
Contraceptive modern method prevalence
37.6%
-0.5%
(2011)
Trinidad and Tobago Antiretroviral therapy coverage between 2000 and 2022
| Period | Antiretroviral therapy coverage | Change |
|---|---|---|
| 2022 | 60% | -1% |
| 2021 | 61% | -1% |
| 2020 | 62% | -5% |
| 2019 | 67% | +6% |
| 2018 | 61% | +4% |
| 2017 | 57% | 0% |
| 2016 | 57% | 0% |
| 2015 | 57% | +3% |
| 2014 | 54% | +2% |
| 2013 | 52% | +5% |
| 2012 | 47% | +5% |
| 2011 | 42% | +3% |
| 2010 | 39% | +9% |
| 2009 | 30% | +6% |
| 2008 | 24% | +4% |
| 2007 | 20% | +4% |
| 2006 | 16% | +3% |
| 2005 | 13% | +4% |
| 2004 | 9% | +3% |
| 2003 | 6% | +3% |
| 2002 | 3% | +2% |
| 2001 | 1% | +1% |
| 2000 | 0% |